Gqg Partners LLC Bristol Myers Squibb CO Transaction History

Gqg Partners LLC

$67 Billion
Q4 2024

A detailed history of Gqg Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gqg Partners LLC holds 52,856 shares of BMY stock, worth $2.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,856

Holding current value

$2.96 Million

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$51.92 - $59.94 $2.74 Million - $3.17 Million	52,856 New	52,856 $2.99 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $31 Million - $35.1 Million	-471,183 Reduced 91.77%	42,232 $2.93 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $3.52 Million - $4.17 Million	51,365 Added 11.12%	513,415 $36.9 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $132,004 - $78 Million	-1,015,421 Reduced 68.73%	462,050 $32.9 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $63.3 Million - $69.7 Million	871,872 Added 143.97%	1,477,471 $114 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $37.2 Million - $44.6 Million	605,599 New	605,599 $44.2 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $915,517 - $1.07 Million	-17,071 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $9,112 - $10,673	-154 Reduced 0.89%	17,071 $1.01 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $424,454 - $462,231	6,856 Added 66.12%	17,225 $1.15 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $266 Million - $299 Million	-4,483,454 Reduced 99.77%	10,369 $655,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $218 Million - $248 Million	3,783,133 Added 532.32%	4,493,823 $279 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $175 Million - $194 Million	-3,044,997 Reduced 81.08%	710,690 $42.8 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $206 Million - $241 Million	3,755,687 New	3,755,687 $221 Million

Others Institutions Holding BMY

# of Institutions

2,656

Shares Held

1.47B

Call Options Held

32.3M

Put Options Held

34.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gqg Partners LLC with notifications on news.

Account